. Author manuscript; available in PMC: 2016 Apr 2.

Published in final edited form as: Breast Cancer Res Treat. 2015 Apr 2;150(3):569–579. doi: 10.1007/s10549-015-3359-6

Table IIA.

PARP1 mean H-score analyzed according to patient and tumor characteristics (Race, ER status, PR status, HER2 status).

		Number	Mean	Std Dev	Median	Minimum	Maximum	LSMean	P-Value

Race	White	152	118	56.60	120	0	265	104.12	0.5057
	Black	154	97.87	62.07	100	0	223.33	99.98
	Other	1	60	---	60	60	60	40.40

ER	ER+	138	96.38	62.40	95.83	0	265	75.32	0.3959
ER	ER-	169	116.96	56.74	116.67	0	223.33	87.68	0.3959

PR	PR+	128	96.47	62.52	95.83	0	265	82.14	0.9300
PR	PR-	179	115.76	57.20	115	0	255	80.86	0.9300

HER2	HER2+	93	117.29	59.70	116.67	0	265	97.95	<0.0001
HER2	HER2-	214	103.55	59.98	104.17	0	220	65.05	<0.0001

Stage	0	1	125	---	125	125	125	54.16	0.7014
	1	77	124.07	55.57	120	0	210	93.89
	2	143	104.46	61.15	103.33	0	265	90.60
	3	74	98.55	61.44	100.83	0	220	80.96